Professor at National Taiwan University, Taiwan
Professional Profiles
Scopus
Orcid
🎓 Academic and Professional Background
Dr. Wen Jen Lin is a distinguished scholar in the field of pharmacy, holding a Ph.D. in Pharmaceutics from the University of Iowa, USA, and an M.S. in Pharmacokinetics from the School of Pharmacy at National Taiwan University. Dr. Lin currently serves as a Professor at the School of Pharmacy and as the Leader of the Pharmaceutical Research Group in the Drug Research Center at the College of Medicine, National Taiwan University.
🧑🔬 Professional Experience and Contributions
Throughout his career, Dr. Lin has made substantial contributions to both academia and the pharmaceutical industry. His roles include serving on advisory committees for Food and Drug Administration (Ministry of Health and Welfare), as a consultant for the Center for Drug Evaluation, and as an editorial board member for the Asian Journal of Pharmaceutical Sciences. He has also been a reviewer for major institutions such as the Council of Agriculture and Ministry of Science and Technology.
🏆 Honors and Awards
Dr. Lin’s expertise and dedication have been widely recognized through multiple awards, including the Senior Teacher Award (2000, 2010), the Ching-Kang Foundation Young Teacher Award (2004), and the Research Award for Academic Performance from National Taiwan University, awarded across multiple years (2007-2010, 2012-2022, 2024). Notably, he was honored with the Professor Li Jhao Ren Foundation Research Scholar Award in 2017, underlining his research impact.
👥 Professional Memberships
Dr. Lin is a permanent member of various esteemed organizations, including The Pharmaceutical Society of Taiwan, Biomaterials and Controlled Release Society of Taiwan, and Taiwan Parenteral Drug Association. His recent affiliation with The Pharmaceutical Society of Japan (2024) highlights his expanding global influence.
🔬 Areas of Research
Dr. Lin’s research specialties span nanomedicine, cancer therapy, pharmacokinetics, and biomaterials, focusing on solutions to critical clinical needs. His early work developed porous polymeric microparticles for protein release, exploring “green synthesis” methods that avoid toxic catalysts. Dr. Lin’s middle-stage research synthesized amphiphilic copolymers forming micelles for drug delivery, which he adapted for targeted therapies in liver and cancer treatment. In recent studies, he addresses challenges in glioma therapy, engineering nanoparticles capable of crossing the blood-brain barrier (BBB) for targeted delivery. Additionally, his innovative oral nanoparticle platform for acid-labile drugs presents promising advancements in gastroesophageal reflux disease treatment, improving bioavailability and sustained drug release.
Publications Top Noted📝
Zein-PEG nanoparticles modified with hyaluronic acid for paclitaxel delivery in SKOV3 ovarian cancer cells
Authors: Lai, M.-H., Lin, W.-J.
Journal: International Journal of Biological Macromolecules
Year: 2024
Improve BBB Penetration and Cytotoxicity of Palbociclib in U87-MG Glioblastoma Cells Delivered by Dual Peptide Functionalized Nanoparticles
Authors: Lo, Y.-C., Lin, W.-J.
Journal: Pharmaceutics
Year: 2023
Synergistic cytotoxicity of irinotecan combined with polysaccharide-based nanoparticles for colorectal carcinoma
Authors: Pai, F.-T., Lin, W.-J.
Journal: Biomaterials Advances
Year: 2023
Benefit of a short chain peptide as a targeting ligand of nanocarriers for a brain-driven purpose
Authors: Lo, Y.-C., Lin, W.-J.
Journal: Pharmaceutics
Year: 2021
Peptide-functionalized nanoparticles-encapsulated cyclin-dependent kinases inhibitor seliciclib in transferrin receptor overexpressed cancer cells
Authors: He, G.Z., Lin, W.-J.
Journal: Nanomaterials
Year: 2021